Buradasınız

Anasayfa » Content

Esansiyel Hipertansif Hastalarda Serum Leptin Seviyesi ve Endotel Fonksiyonu Arasındaki İlişki

Relation Between Endothelial Function and Leptin Level in Essential Hypertensive Patients

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2006

Key Words:

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Insulin resistance and sympathetic activation are shown to play a role in the pathogenesis of essential hypertension. The ro¬ le of sympathetic activation in essential hypertension has been documented by a variety of tecniques. It has been known that leptin, produced by mainly adipose tissue, play a role in the pathogenesis of hypertension by causing sympathetic activation. Besi¬ des that, leptin may cause oxidative stress in endothelial cells by inducing free oxygen radicals. Both oxidative stress and sympat¬ hetic activation may be a cause of endothelial dysfunction, desc¬ ribed as an impairment of endothelium-dependent vasodilatation, seen also in essential hypertensive patients. In v i ew of these data, in this study we aimed to investigate a relation between endothelium- dependent dilatation and leptin in patients with essential hypertension. Thirty-five patients with essential hypertension (age: 44.2±7.1, male/female: 19/16) and age and gender matched 38 healty controls (age:44.8 ± 5.6, male/female:20/18) were included in this study. The measurements of endothelial function were done by ultrasonography described by Celermajer et al. Serum leptin levels d id not differ significantly between the two groups (3.86±4.4, 3.01±3.2 p>0. 05). Flow and nitrate mediated dilatation were found to be reduced in hypertensive group when compared to control group. Flow mediated dilatation: 5.2±3.2 vs 12.7±3.6, p<0.001; nitrate mediated dilatation: 17.2±5.8 vs 22.4±5.5, p<0.001. Although there were positive relation of leptin with body mass index and adipose tissuemass (respectively; r=0.47 ve r=0.50, p<0.01), there were no relation between leptin and flow and nitrate mediated dilatation (r=-0.042 r=-0.038, p>0.05). As a conclusions; essential hypertensive patients were characterized by endothelial dysfunction. In additon, there was no relation between leptin and endothelial function in essential hypertensive patients.
Bookmark/Search this post with
Abstract (Original Language): 
Insulin direnci ve sempatik aktivasyon esansiyel hipertansiyon patogenezinde rol oynamaktadır. Esansiyel hipertansif hastalarda sempatik aktivasyon varlığı farklı yöntemlerle gösterilmiştir. Başlıca yağ dokusunda sentezlenen leptinin de sempatik aktivasyona yol açarak esansiyel hipertansiyon patogenezinde rol oynadığı bilinmektedir. Ayrıca leptin, endotel hücrelerinden serbest oksijen radikali oluşturarak oksidatif stres oluşumuna neden olabilmektedir. Hem oksidatif stres hem de sempatik aktivasyon endotele bağlı dilatasyonun bozulması olarak tanımlanan ve esansiyel hipertansi¬ yon hastalarında görülen endotel disfonksiyonuna yol açabilmekte¬ dir. Bu bilgilerin ışığında, bu çalışmada, esansiyel hipertansif hastalarda serum leptin seviyesi ile endotel fonksiyonu arasındaki ilişkinin araştırılması amaçlanmıştır. Çalışmaya 35 esansiyel hipertansiyon hastası (yaş: 44.2±7.1, erkek/kadın: 19/16) ve demografik özellikleri benzer 38 sağlıklı kontrol (yaş: 44.8±5.6, erkek/kadın: 20/18) dahil edildi. Hastaların endotel fonksiyonları daha önce Celermajer ve arkadaşlarının tarif ettiği şekilde ultrasonografik ölçümle değerlendirildi. Serum leptin seviyesi hasta ve sağlıklı kontrol grubunda karşılaştırıldığında her iki grup arasında fark bulunmamaktaydı (3.86±4.4, 3.01±3.2 p>0.05). Endotel fonksiyonunun göstergesi olan akıma bağlı dilatasyon, hipertansif grupta kontrol grubu ile karşılaştırıldığında istatistiksel olarak anlamlı derecede azalmış bulundu (%5.2±3.2'ye karşı %12.7±3.6 p<0.001).Aynı zamanda hipertansif hasta grubunda nitrata bağlı dilatasyon da sağlıklı kontrol grubu ile karşılaştırıldığında istatistiksel olarak anlamlı derecede düşük saptandı (%17.2±5.8'ye karşı %22.4±5.5 p<0.001). Leptinin vücut kitle indeksi VKİ (kg/m2), yağ miktarı (kg) ile istatistiksel olarak anlamlı pozitif bir ilişkisi bulunmasına rağmen (sırasıyla; r=0.47 ve r=0.50, p<0.01), akıma bağlı dilatasyonla ve nitrata bağlı dilatasyonla ilişkisi bulunmamaktaydı (sırasıyla r=- 0.042 ve r=-0.038, p>0.05). Sonuç olarak, esansiyel hipertansif hastalar endotel disfonksi-yonuyla karakterize olup, serum leptin seviyesi ile endotel fonksi¬yonu seviyesi arasında ilişki bulunmamaktadır.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_15_pp_207-212.pdf
  • 4
207-212
  • Turkish

REFERENCES

References: 

1. Kannel WB, Neaton JD, Wenvord JD et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT (Multiple risk factor intervention trial). Am Heart J 1986;112:825-836.
2. Smith Wm. Treatment of mild hypertension results of ten ye¬ars intervention trial. Circ Res 1977;40 (suppl 1):98-105.
3. Anderson TJ. Assesment and treatment of endothelial dysfunction in humans. Journal of the American College of
Cardiology 1999;34:631-638.
4. Taddei S, Virdis A, Ghiadoni L. Effect of antihypertensive drugs on endothelial dysfunction. Drugs 2002;62(2):265-284.
5. Hijmering ML, Stroes ES, Olijhoek K et al. Sympathetic activation markedly reduces endothelium-dependent, flow mediated dilatation. J Am Coll Cardiol 2002;39:683-688.
6. Sever PS. The heterogeneity of hypertension: why doesn't every patient respond to every antihypertensive drug. J Hum
Hypertens 1995;Suppl 2:S33-S36.
7. Mancia G, Grassi G, Giannattasio C et al. Sympathetic activa¬tion in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999;34:724-788.
8. Ferrannini E, Buzzigoli G, Bonadonno R et al. Insulin resis¬tance in essential hypertension. N Engl J Med. 1987;317:350-357.
9. Grassi G, Esler M. How to assess sympathetic activity in hu¬mans. Journal of Hypertension 1999;17:719-734.
10. Mcfarlene SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001;86:713-
718.
11. Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH. Relation
of body fat topography to insulin sensitivity and metabolic
Official Journal of the Turkish Society of Nephrology / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi
211
0 Relation Between Endothelial Function and Leptin Level in Essestial Hypertensive Patients
profile in premenopausal women. Metabolism 1984;36.68-75.
12. Steppan CM, Lazar MA. Resistin and obesity-associated insu¬lin resistance. Trends in Endocrinol Metab 2002;13:18-23.
13. Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature
1994;372:425-432.
14. Wolf G, Chen S, Han DC et al. Leptin and renal disease.
AJKD 2002;39:1-11.
15. Haynes WG, Morgan DA, Walsh SA. Receptor mediated regi¬onal sympathetic nerve activation by leptin. J Clin Invest 1997;100:270-278.
16. Agata J, Masuda A, Takada M et al. High plasma immunore-active leptin level in essential hypertension. Am J Hypertens
1997;10:1171-1174.
17. Chobanian AV, Bakris GL, Black HR et al and the National High Blood Pressure Education Program Coordinating Com¬mittee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572.
18. Segal KR, Van Loan M, Fitzgerald PI et al. Lean body mass es¬timation by bioelectrical impedance analysis: a four site-cross validation study. Am J Clin Nutr 1988;47:7-14.
19. Celermajer DC, Soronsen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
20. Linder l, Kiowski W, Buhler FR et al. Indirect evidence for the release of endothelium- derived relaxing factor in human fo¬rearm circulation in vivo: blunted response in essential hypertension. Circulation 1990;81:1762-1767.
21. Panza JA, Quyyumi AA, Brush JE jr, Epstein SE. Abnormal en-dothelium dependent vascular relaxation in patients with es¬sential hypertension. N Engl J Med 1990;323:22-27.
22. Zizek B, Poredos P, Videcnik V. Endothelial dysfunction in hypertensive patients and in normotensive offspring of sub¬jects with essential hypertension. Heart 2001;85:215-217.
23. Iiyama K, Nagano M, Yo Y et al. Impaired endothelial functi¬on with essential hypertension assessed by ultrasonography.
Am Heart J 1996;132(4)779-782.
24. Mallamaci F, Cuzzala F, Tripepi G et al. Gender dependent differences in plasma leptin in essential hypertension. Am J
Hypertens 2000;13:914-920.
25. Sheu WH, Lee WJ, Chen YT High Plasma leptin concent¬rations in hypertensive men not in hypertensive women. J
Hypertens 1999;17:1289-1295.
26. Rosenbaum M, Nicolson M, Hirsch J et al. Effects of gender, body composition and menopause on plasma concentrations
of leptin. J Clin Endocrinol Metab 1996;81:3424-3427.
27. Wallace AM, McMahon AD, Packard CJ et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study. Circulation 2001;104:3052-3056.

Thank you for copying data from http://www.arastirmax.com